Related Experiment Videos
Reporting outcomes in Hodgkin's disease and lymphoma
D O Dixon1, P McLaughlin, F B Hagemeister
1Department of Biomathematics, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
On the ethical aspects of the testimony of statisticians in court.
Statistical methods in medical research·2002
The role of the biostatistician in cancer research.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2002
Biostatistics in the new millennium: a consulting statistician's perspective.
Statistical methods in medical research·2000
Should data and safety monitoring boards share confidential interim data?
Controlled clinical trials·2000
A modification of Simon's optimal design for phase II trials when the criterion is median sample size.
Controlled clinical trials·1999
Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
Medical and pediatric oncology·1999
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
The Patient Who Could Not Die.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Phenotypic clustering and ABC pathway adherence in patients with atrial fibrillation at high risk of bleeding and stroke: Insights from three global registries.
European journal of internal medicine·2026
Cardiovascular disease burden at cancer diagnosis: temporal trends in a national study from England.
European heart journal·2026
Cardiovascular-Kidney-Metabolic Syndrome Age Derived From Routine Health Checkup and Claims Data - Large-Scale Epidemiological Study.
Circulation journal : official journal of the Japanese Circulation Society·2026
Vascular medicine in older adults - A call for structured cooperation to improve care.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Age-specific coronary outcomes in subacute Kawasaki disease.
American heart journal·2026